As of
© Modular Finance, source
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.268 SEK | -0.37% |
|
-3.04% | -97.29% |
05-22 | Xbrane Successfully Scale Up Xdivane- Biosimilar Candidate to Opdivo®? | CI |
05-16 | Transcript : Xbrane Biopharma AB, Q1 2024 Earnings Call, May 16, 2024 |
As of
© Modular Finance, source
1st Jan change | Capi. | |
---|---|---|
-97.29% | 38.94M | |
+23.13% | 46.93B | |
+37.23% | 39.08B | |
-8.73% | 38.48B | |
+28.09% | 31.01B | |
-12.26% | 26.14B | |
+10.57% | 25.88B | |
+45.05% | 14.15B | |
+32.23% | 12.53B | |
-6.56% | 11.36B |